Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
4.315
-0.015 (-0.35%)
At close: May 28, 2025, 4:00 PM
4.310
-0.005 (-0.12%)
After-hours: May 28, 2025, 4:37 PM EDT
Vanda Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 3 professional analysts, the 12-month price target for Vanda Pharmaceuticals stock ranges from a low of $13 to a high of $20. The average analyst price target of $15.33 forecasts a 255.27% increase in the stock price over the next year.
Price Target: $15.33 (+255.27%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Vanda Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Buy | 1 | 1 | 1 | 1 | 1 | 2 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 2 | 3 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $13 | Buy | Initiates | $13 | +201.27% | May 14, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +363.50% | May 7, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +363.50% | Apr 1, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $18 → $20 | Strong Buy | Maintains | $18 → $20 | +363.50% | Feb 18, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +317.15% | Feb 4, 2025 |
Financial Forecast
Revenue This Year
232.28M
from 198.77M
Increased by 16.86%
Revenue Next Year
324.68M
from 232.28M
Increased by 39.78%
EPS This Year
-1.52
from -0.33
EPS Next Year
-0.39
from -1.52
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | 239.5M | 365.9M | 384.9M |
Avg | 232.3M | 324.7M | 373.9M |
Low | 222.5M | 280.8M | 359.3M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | 20.5% | 57.5% | 18.6% |
Avg | 16.9% | 39.8% | 15.2% |
Low | 11.9% | 20.9% | 10.7% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | -1.45 | 0.07 | -0.03 |
Avg | -1.52 | -0.39 | -0.03 |
Low | -1.52 | -1.23 | -0.03 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.